Form 4 Filing for COGNITION THERAPEUTICS INC

This filing details significant insider transactions for COGNITION THERAPEUTICS INC (CGTX) on December 18, 2025. Anthony Caggiano, Chief Medical Officer, acquired 65,000 shares of Common Stock through the vesting of performance stock units (PSUs) with no price per share, increasing his holdings to 528,273 shares. In a separate transaction, 20,280 shares were withheld by the issuer to cover tax obligations related to PSU vesting, resulting in a net post-transaction share count of 507,993 shares. These transactions are reported on a Form 4, indicating changes in beneficial ownership.